MRI for New Headache: Contrast Recommendation
For a new headache warranting MRI, start with MRI brain WITHOUT contrast in most cases, reserving contrast administration only for specific red flag scenarios or when initial non-contrast sequences reveal suspicious findings.
Primary Recommendation
The evidence does not support routine gadolinium contrast for initial evaluation of new headache. A recent 2026 study of 435 emergency MRI examinations for acute isolated headache found that no diagnosis relied exclusively on contrast for initial detection 1. Headache-related findings were identified in only 10% of patients, with serious pathology like cerebral venous thrombosis (CVT) occurring in just 0.7% of cases—and critically, all confirmed CVT cases showed abnormalities on pre-contrast sequences 1.
When to Add Contrast
Add gadolinium contrast if:
- Suspicious lesions appear on non-contrast sequences requiring characterization (tumors, inflammatory lesions, infections)
- Clinical red flags suggest specific pathologies:
- Suspected meningitis or encephalitis
- Known or suspected malignancy
- Immunocompromised patients
- Progressive neurologic deficits beyond headache alone
- Suspected demyelinating disease (though this is typically not "new headache" presentation)
Clinical Algorithm
Initial scan: MRI brain without contrast
- Includes standard sequences: T1, T2, FLAIR, DWI, SWI/GRE
- Add MRV (without contrast) if pseudotumor cerebri or venous thrombosis suspected clinically
Review non-contrast sequences immediately
- If normal → diagnosis complete, no contrast needed
- If suspicious findings → proceed to contrast-enhanced sequences
Contrast administration only when:
- Mass lesion identified needing characterization
- Inflammatory/infectious process suspected
- Vascular abnormality requiring better delineation
Evidence Strength and Nuances
The 2026 emergency headache study 1 provides the most direct evidence for this approach, demonstrating that a non-contrast-first strategy would markedly reduce gadolinium administrations while preserving detection of serious pathology. This aligns with broader trends in neuroimaging to minimize gadolinium exposure due to brain deposition concerns and environmental impact.
Important caveat: Older literature from 1996 2 and a 2013 case report 3 suggested contrast-enhanced CT might detect meningiomas missed on non-contrast imaging. However, these studies used CT (not MRI) and predated modern high-resolution MRI sequences. Current MRI without contrast has superior soft tissue resolution compared to non-contrast CT and can detect most structural lesions.
Common Pitfalls to Avoid
- Don't reflexively order contrast based on outdated protocols that assumed all brain MRIs required gadolinium
- Don't confuse "new headache" with "new neurologic deficit"—the latter requires different imaging considerations per ACR guidelines 4
- Don't skip MRV if clinical features suggest increased intracranial pressure or venous thrombosis (papilledema, positional headache, recent prothrombotic state)
- Don't use contrast-only sequences—if contrast is needed, always obtain pre-contrast images for proper comparison 5
Cost and Safety Considerations
An unenhanced MRI-first approach significantly reduces:
- Healthcare costs (gadolinium agents are expensive)
- Examination time (faster throughput, less sedation time in children)
- Gadolinium brain deposition (particularly relevant with repeated imaging)
- Environmental gadolinium contamination
- Risk in patients with renal impairment
This evidence-based approach balances diagnostic accuracy with patient safety and resource stewardship, reserving contrast for cases where it provides genuine diagnostic value rather than routine administration.